Pseudomonas aeruginosa is an important life-threatening nosocomial nosocomial pathogen that plays an important role in wound infections of burn patients. Burn injury is one of the most common and devastating forms of trauma and is an important public health problem worldwide. Burn infection is common because the skin, which acts as a physical barrier against germs, is compromised. Pseudomonas aeruginosa is the most common source of burn wound infections. These bacteria tend to cause disease in immunocompromised patients, such as AIDS, cystic fibrosis, and burn patients, but rarely in healthy people. Accurate identification of Pseudomonas aeruginosa and determination of its antimicrobial susceptibility are critical factors in burn patient management.
Despite the large amounts of pseudomonas aeruginosa frequently encountered in clinical specimens from burn patients, isolation and identification are not easy for microbiology laboratories. Difficulties in recognizing this bacterium are compounded by difficulties in biochemical identification. Biochemical test kits are commonly used for identification. Pseudomonas aeruginosa has natural resistance to antibiotics and antiseptics.
Tech agar is an effective, simple and economical medium for the identification of pseudomonas aeruginosa and is used as a unique test for all potential pseudomonas aeruginosa isolates.
Pseudomonas aeruginosa bacteria are of little concern to those who are healthy and strong, but can be deadly for those whose health is not so robust. Therefore, it causes serious infections in people who are sick and treated in hospital. Those with weakened immune systems or health conditions that make them more susceptible to illness are at risk of being severely affected if they encounter the bacteria. Pseudomonas aeruginosa has the power to potentially kill patients in hospitals within 24 hours of being infected. Even when the person survives, the disease is severe. It mostly causes respiratory system problems, and infections trigger cases of pneumonia and septicemia.
In most cases, bacterial infections are successfully treated with antibiotics. However, pseudomonas aeruginosa has developed resistance to antibiotics. In this regard, good personal and environmental hygiene and cleaning and disinfection procedures are vital in hospitals and healthcare facilities.
Our organization, among the numerous test, measurement, analysis and evaluation studies it provides for businesses in various sectors, also provides testing services for the determination of pseudomonas aeruginosa with its trained and expert staff and advanced technological equipment.
To get an appointment, to get more detailed information or to request an evaluation, you can ask us to fill in our form and reach you.
EUROLAB reporting and certification activities, United Accreditation Foundation (UAF), Turkish Accreditation Agency (TÜRKAK), Enterprise Accreditation Foundation (EAF) based on the accreditation provided by its institution. The Enterprise Accreditation Foundation (EAF) is also a signatory to the United Nations (UN GLOBAL COMPACT).
